Randomised crossover trial of a novel and traditional Continuous Positive Airway Pressure (CPAP) system in Obstructive Sleep Apnoea patients.

Inclusion Criteria

• Participant is willing to provide written informed consent
• Participant is able to read and comprehend written and spoken English
• Participant is ≥ 18 years of age
• Participant has been diagnosed with Obstructive Sleep Apnoea (OSA)
• Participants has been established on Continuous Positive Airway Pressure (CPAP) for ≥ 6 months
• Participants is currently using the same mask type/variant as the interventional mask system to be evaluated
• Participants is able to participate for the duration of the study

Exclusion Criteria

• Participant is not willing to provide written informed consent
• Participant is unable to read and comprehend written and spoken English
• Participant is < 18 years of age
• Participant has not been diagnosed with Obstructive Sleep Apnoea (OSA)
• Participant has not been established on Continuous Positive Airway Pressure (CPAP) for ≥ 6 months
• Participant is not currently using the same mask type/variant as the interventional mask system to be evaluated
• Participant is unable to participate for the duration of the study
• Participant is pregnant
• Participant is established on bi-level support therapy
• Participant, or participants bed partner, has metallic implants in head neck or chest
• Participant has a with a pre-existing lung disease or a condition that would predispose them to pneumothorax (e.g. Chronic Obstructive Pulmonary Disease (COPD), lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection, lung injury)
• Participant is unsuitable to participate in the study in the opinion of the researcher